Precision oncology is the proof of principle. It’s just a matter of time before such personalized tests and treatments become mainstream in other specialties, from rheumatology to endocrinology to psychiatric care.
In an interview at ASCO 2017, head of the Prostate Cancer Foundation Jonathan Simons was heralding one of the biggest strides the field has seen in treating the most advanced form of the disease.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Running low on talking points for your liquid biopsy watercooler chats? Fear not. An education session at ASCO 2017 highlighted some of the latest findings from the field — and we have a recap of that recap here.
You know you’re on to something worthwhile when your study leader can't quite hold back the tears when presented with the final data. On Monday, Bluebird Bio will share that same data at ASCO 2017.
New York City-based Medidata is building a case for the efficacy of its "synthetic control arm" service for clinical trials, which takes matching historical controls to a whole new level.